People: Acura Pharmaceuticals Inc (ACUR.O)
ACUR.O on Consolidated Issue listed on NASDAQ Capital Market
2.36USD
23 May 2013
2.36USD
23 May 2013
Price Change (% chg)
$0.02 (+0.85%)
$0.02 (+0.85%)
Prev Close
$2.34
$2.34
Open
$2.27
$2.27
Day's High
$2.39
$2.39
Day's Low
$2.25
$2.25
Volume
267,979
267,979
Avg. Vol
736,988
736,988
52-wk High
$4.50
$4.50
52-wk Low
$1.06
$1.06
Wesson, Bruce
Brief Biography
Mr. Bruce F. Wesson is an Independent Director of Acura Pharmaceuticals, Inc., since March 1998. From January 1991 until June 30, 2011 Mr. Wesson was a Partner of Galen Associates, a health care venture firm, and a General Partner of Galen Partners III, L.P. Prior to January, 1991, he was Senior Vice President and Managing Director of Smith Barney, Harris Upham & Co. Inc., an investment banking firm. He serves on the Boards of Derma Sciences, Inc., and as Vice Chairman of the Board of MedAssets, Inc., each a publicly traded company. Mr. Wesson earned a Bachelor of Arts degree from Colgate University and a Masters of Business Administration from Columbia University.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Robert Jones |
602,353 |
Peter Clemens |
340,863 |
Robert Seiser |
267,490 |
J. Bradley Rivet |
352,988 |
Albert Brzeczko |
452,608 |
James Emigh |
267,490 |
As Of 30 Dec 2012

